| No | Primary DI | Version or Model | Catalog Number | Device Description | Product Code | Product Code Name | Device Class | Brand Name |
|---|---|---|---|---|---|---|---|---|
| 1 | 08033549790967 | 651-140 | 1517000 | Medtronic MeroGel Nasal Dressing/Sinus stent and Otologic Packing is used in the Medtronic MeroGel Nasal Dressing/Sinus stent and Otologic Packing is used in the nasal/sinus and the middle ear/external ear canal as a space occupying dressing and/or stent, to separate mucosal surfaces and to help control minimal bleeding following surgery, and in otologic packing, to act as an adjunct to aid in the natural healing process. | EMX | Balloon, Epistaxis | 1 | Merogel Nasal Dressing/Sinus Stent &Otologic Packing 4x4cm |
| 2 | 08033549790950 | 651-141 | 1517002 | Medtronic MeroGel Nasal Dressing/Sinus stent and Otologic Packing is used in the Medtronic MeroGel Nasal Dressing/Sinus stent and Otologic Packing is used in the nasal/sinus and the middle ear/external ear canal as a space occupying dressing and/or stent, to separate mucosal surfaces and to help control minimal bleeding following surgery, and in otologic packing, to act as an adjunct to aid in the natural healing process. | EMX | Balloon, Epistaxis | 1 | Merogel Nasal Dressing/Sinus Stent &Otologic Packing 2pk 4x4cm |
| 3 | 08033549790721 | 651-140 | 1517000 | Medtronic MeroGel Nasal Dressing/Sinus stent and Otologic Packing is used in the Medtronic MeroGel Nasal Dressing/Sinus stent and Otologic Packing is used in the nasal/sinus and the middle ear/external ear canal as a space occupying dressing and/or stent, to separate mucosal surfaces and to help control minimal bleeding following surgery, and in otologic packing, to act as an adjunct to aid in the natural healing process. | EMX | Balloon, Epistaxis | 1 | Merogel Nasal Dressing/Sinus Stent &Otologic Packing 4x4cm |
| 4 | 08033549790714 | 651-141 | 1517002 | Medtronic MeroGel Nasal Dressing/Sinus stent and Otologic Packing is used in the Medtronic MeroGel Nasal Dressing/Sinus stent and Otologic Packing is used in the nasal/sinus and the middle ear/external ear canal as a space occupying dressing and/or stent, to separate mucosal surfaces and to help control minimal bleeding following surgery, and in otologic packing, to act as an adjunct to aid in the natural healing process. | EMX | Balloon, Epistaxis | 1 | Merogel Nasal Dressing/Sinus Stent &Otologic Packing 2pk 4x4cm |
| 5 | 00866142000052 | 6000000 | 0.8 ml, 1.2% OVD Sodium Hyaluronate | LZP | Aid, Surgical, Viscoelastic | 3 | Anikavisc | |
| 6 | 00866142000045 | 600-106 | 0.8 ml, 12 mg/mL Sodium Hyaluronate | LZP | Aid, Surgical, Viscoelastic | 3 | Anikavisc | |
| 7 | 00866142000021 | 600-809 | 0.8 ml, 12 mg/mL Sodium Hyaluronate | LZP | Aid, Surgical, Viscoelastic | 3 | Staarvisc II | |
| 8 | 00817337000111 | 630254 | Mitek Orthovisc, 2 mL, US | MOZ | Acid, Hyaluronic, Intraarticular | 3 | Orthovisc | |
| 9 | 30886158020067 | 600-108 | 0.8 ml, 1.2% OVD Sodium Hyaluronate | LZP | Aid, Surgical, Viscoelastic | 3 | NuVisc | |
| 10 | 10886705023110 | 630-254 | 2 mL, 15 mg/mL High Molecular weight Hyaluronan | MOZ | Acid, Hyaluronic, Intraarticular | 3 | Orthovisc | |
| 11 | 08033549791063 | 653-200 | 1417000 | Epifilm Otologic Lamina is intended for use as an implant material to aid in sur Epifilm Otologic Lamina is intended for use as an implant material to aid in surgical repairs and as an adjunct to aid in the natural healing process in various otologic procedures. | KHJ | Polymer, Ent Synthetic-Polyamide (Mesh Or Foil Material) | 2 | Epifilm Otologic |
| 12 | 08033549791025 | 653-300 | 1417100 | EpiDisc Otologic Lamina is used as an implant material to aid in surgical repair EpiDisc Otologic Lamina is used as an implant material to aid in surgical repairs and as an adjunct to aid in the natural healing process in various otologic procedures. | KHJ | Polymer, Ent Synthetic-Polyamide (Mesh Or Foil Material) | 2 | Epidisc 2pk Otologic 8mm |
| 13 | 08033549791018 | 653-200 | 1417000 | Epifilm Otologic Lamina is intended for use as an implant material to aid in sur Epifilm Otologic Lamina is intended for use as an implant material to aid in surgical repairs and as an adjunct to aid in the natural healing process in various otologic procedures. | KHJ | Polymer, Ent Synthetic-Polyamide (Mesh Or Foil Material) | 2 | Epifilm Otologic |
| 14 | 08033549790981 | 653-300 | 1417100 | EpiDisc Otologic Lamina is used as an implant material to aid in surgical repair EpiDisc Otologic Lamina is used as an implant material to aid in surgical repairs and as an adjunct to aid in the natural healing process in various otologic procedures. | KHJ | Polymer, Ent Synthetic-Polyamide (Mesh Or Foil Material) | 2 | Epidisc 2pk Otologic 8mm |
| 15 | 08033549790974 | 653-200 | 1417000 | Epifilm Otologic Lamina is intended for use as an implant material to aid in sur Epifilm Otologic Lamina is intended for use as an implant material to aid in surgical repairs and as an adjunct to aid in the natural healing process in various otologic procedures. | KHJ | Polymer, Ent Synthetic-Polyamide (Mesh Or Foil Material) | 2 | Epifilm Otologic |
| 16 | 08033549790745 | 653-300 | 1417100 | EpiDisc Otologic Lamina is used as an implant material to aid in surgical repair EpiDisc Otologic Lamina is used as an implant material to aid in surgical repairs and as an adjunct to aid in the natural healing process in various otologic procedures. | KHJ | Polymer, Ent Synthetic-Polyamide (Mesh Or Foil Material) | 2 | Epidisc 2pk Otologic 8mm |
| 17 | 08033549790738 | 653-200 | 1417000 | Epifilm Otologic Lamina is intended for use as an implant material to aid in sur Epifilm Otologic Lamina is intended for use as an implant material to aid in surgical repairs and as an adjunct to aid in the natural healing process in various otologic procedures. | KHJ | Polymer, Ent Synthetic-Polyamide (Mesh Or Foil Material) | 2 | Epifilm Otologic |
| 18 | 07391899830612 | 600-806 | 0.8 ml, 1.2% Sodium Hyaluronate | LZP | Aid, Surgical, Viscoelastic | 3 | Amvisc | |
| 19 | 00866142000007 | 685-015 | Cross-Linked Hyaluronic Acid and Lidocaine Injectable Gel | LMH | Implant, Dermal, For Aesthetic Use | 3 | Hydrelle | |
| 20 | 10886705025183 | 690-016 | 4 mL, 22 mg/mL High Molecular Weight Hyaluronan | MOZ | Acid, Hyaluronic, Intraarticular | 3 | Monovisc | |
| 21 | 08033549791001 | 651-142 | 1517100 | MeroGel Otologic Packing is a space occupying dressing and/or stent intended to MeroGel Otologic Packing is a space occupying dressing and/or stent intended to separate mucosal surfaces, help control minimal bleeding and act as an adjunct to aid in the natural healing process. | KHJ | Polymer, Ent Synthetic-Polyamide (Mesh Or Foil Material) | 2 | MeroGel Otologic Packing 1x5cm |
| 22 | 08033549790776 | 651-142 | 1517100 | MeroGel Otologic Packing is a space occupying dressing and/or stent intended to MeroGel Otologic Packing is a space occupying dressing and/or stent intended to separate mucosal surfaces, help control minimal bleeding and act as an adjunct to aid in the natural healing process. | KHJ | Polymer, Ent Synthetic-Polyamide (Mesh Or Foil Material) | 2 | MeroGel Otologic Packing 1x5cm |
| 23 | 00866142000038 | 600-105 | 0.8 mL, 12 mg/mL Sodium Hyaluronate | LZP | Aid, Surgical, Viscoelastic | 3 | Optivisc | |
| 24 | 08033549790769 | 640-023 | CFN 1518000 | MEROGEL Injectable is a bioresorbable nasal dressing and sinus stent and otologi MEROGEL Injectable is a bioresorbable nasal dressing and sinus stent and otologic gel designed to help control bleeding and to create a physical separation of mucosal surfaces with the purpose of preventing adhesions during the post-operative healing process | NHB | Polymer, Ear, Nose And Throat, Synthetic, Absorbable | 2 | Merogel Injectable |
| 25 | 00817337000012 | 600-801 | 0.8 ml, 12 mg/mL Sodium Hyaluronate | LZP | Aid, Surgical, Viscoelastic | 3 | Precision Lens Ophthalmic | |
| 26 | 07391899830605 | 655-806 | 0.8 ml, 1.6% Sodium Hyaluronate | LZP | Aid, Surgical, Viscoelastic | 3 | Amvisc Plus | |
| 27 | 00817337000128 | 6000080 | 0.8 ml, 1.2% OVD Sodium Hyaluronate | LZP | Aid, Surgical, Viscoelastic | 3 | Ophthalin | |
| 28 | 00817337000050 | 6000041 | SCS 17-01 is a synthetic, injectable, settable osteoconductive calcium phosphate SCS 17-01 is a synthetic, injectable, settable osteoconductive calcium phosphate bone graft substitute material. | MQV | Filler, Bone Void, Calcium Compound | 2 | SCS 17-01 | |
| 29 | 00866142000014 | 685-310 | Cross-Linked Hyaluronic Acid and Lidocaine Injectable Gel | LMH | Implant, Dermal, For Aesthetic Use | 3 | Elevess | |
| 30 | 00817337000074 | 6000041 | Tactoset is a synthetic, injectable, settable osteoconductive calcium phosphate Tactoset is a synthetic, injectable, settable osteoconductive calcium phosphate bone graft substitute material. | MQV | Filler, Bone Void, Calcium Compound | 2 | Tactoset | |
| 31 | 08033549791032 | 653-160 | 1417151 | EpiDisc TM Perf. Patch Kit is used during myringoplasty as an adjunct to aid in EpiDisc TM Perf. Patch Kit is used during myringoplasty as an adjunct to aid in the healing of tympanic membrane perforations. | KHJ | Polymer, Ent Synthetic-Polyamide (Mesh Or Foil Material) | 2 | EpiDisc TM Perf Patch Kit |
| 32 | 08033549790998 | 653-160 | 1417151 | EpiDisc TM Perf. Patch Kit is used during myringoplasty as an adjunct to aid in EpiDisc TM Perf. Patch Kit is used during myringoplasty as an adjunct to aid in the healing of tympanic membrane perforations. | KHJ | Polymer, Ent Synthetic-Polyamide (Mesh Or Foil Material) | 2 | EpiDisc TM Perf Patch Kit |
| 33 | 08033549790752 | 653-160 | 1417151 | EpiDisc TM Perf. Patch Kit is used during myringoplasty as an adjunct to aid in EpiDisc TM Perf. Patch Kit is used during myringoplasty as an adjunct to aid in the healing of tympanic membrane perforations. | KHJ | Polymer, Ent Synthetic-Polyamide (Mesh Or Foil Material) | 2 | EpiDisc TM Perf Patch Kit |
| No | Primary DI | Version or Model | Catalog Number | Device Description | Brand Name | Organization Name |
|---|---|---|---|---|---|---|
| 1 | 00087541300912 | 00-1111-001-00 | 00-1111-001-00 | Gel-One is a cross-linked hyaluronate hydrogel that is indicated for the treatme Gel-One is a cross-linked hyaluronate hydrogel that is indicated for the treatment of pain in osteoarthritis (OA) of the knee in patients who have failed to respond adequately to non-pharmacologic therapy, non-steroidal anti-inflammatory drugs (NSAIDs) or analgesics (e.g., acetaminophen). Gel-One is physician-administered, and is injected directly into the cavity of the knee joint. It is delivered via a single-use, pre-filled disposable glass syringe containing 3 mL of Gel-One. | Gel-One® Cross-linked Hyaluronate | SEIKAGAKU CORPORATION |
| 2 | 75060432190001 | None | Orthovisc | FCL HEALTH SOLUTIONS LTD | ||
| 3 | 54158041000006 | 024 | Euflexxa | 9902392 CANADA INC | ||
| 4 | 45060432190000 | NA | Euflexxa | FCL HEALTH SOLUTIONS LTD | ||
| 5 | 35060432190003 | None | injectable (hyaluronic acid, intra-articular) | HYALGAN | FCL HEALTH SOLUTIONS LTD | |
| 6 | 25060432190006 | HYLAN GF-20 | injectable (hyaluronic acid, intra-articular) | SYNVISC | FCL HEALTH SOLUTIONS LTD | |
| 7 | 20358468019114 | 002401 | Acid, Hyaluronic, Intraarticular | Synvisc-One® | GENZYME CORPORATION | |
| 8 | 15060432190009 | HYLAN GF-20 | Acid, Hyaluronic, Intraarticular | SYNVISC ONE | FCL HEALTH SOLUTIONS LTD | |
| 9 | M717715655550 | 89130-5555-01 | 7156-5555 | SUPARTZ (P980044) is indicated for treatment of pain in osteoarthritis (OA) of t SUPARTZ (P980044) is indicated for treatment of pain in osteoarthritis (OA) of the knee in patients who have failed to respond adequately to conservative non-pharmacologic therapy and simple analgesics, e.g., acetaminophen. SUPARTZ is a sterile, viscoelastic, non-pyrogenic solution (pH of 6.8-7.8) of highly purified, high molecular weight hyaluronic acid (HA) (620 000-1 170 000 daltons). HA, which is extracted from rooster combs, is a polysaccharide containing repeating disaccharide units of glucuronic acid and N-acetylglucosamine. HA is a common constituent of the extracellular matrix of connective tissues. SUPARTZ is supplied sterile in single-use, pre-filled, disposable plastic syringes, each containing 25 mg of HA dissolved in a Phosphate Buffered Saline (PBS) solution (2.5 mL of 1.0% solution). | SUPARTZ® sodium hyaluronate | SEIKAGAKU CORPORATION |
| 10 | M717715644440 | 89130-4444-1 | 7156-4444 | SUPARTZ FX (P980044) is indicated for treatment of pain in osteoarthritis (OA) o SUPARTZ FX (P980044) is indicated for treatment of pain in osteoarthritis (OA) of the knee in patients who have failed to respond adequately to conservative non-pharmacologic therapy and simple analgesics, e.g., acetaminophen. SUPARTZ FX is a sterile, viscoelastic, non-pyrogenic solution (pH of 6.8-7.8) of highly purified, high molecular weight hyaluronic acid (HA) (620 000-1 170 000 daltons). HA, which is extracted from chicken combs, is a polysaccharide containing repeating disaccharide units of glucuronic acid and N-acetylglucosamine. HA is a common constituent of the extracellular matrix of connective tissues. SUPARTZ FX is supplied sterile in single-use, pre-filled, disposable plastic syringes, each containing 25 mg of HA dissolved in a Phosphate Buffered Saline (PBS) solution (2.5 mL of 1.0% solution). | SUPARTZ FX sodium hyaluronate | SEIKAGAKU CORPORATION |
| 11 | M71389122496630SAM1 | FID185704 | FID185704 | HYMOVIS® is based on an ultra-pure hyaluronan engineered using a proprietary pro HYMOVIS® is based on an ultra-pure hyaluronan engineered using a proprietary process to increase viscosity, elasticity and residence time without chemical crosslinking.The hyaluronan in HYMOVIS® is derived from bacterial fermentation. HYMOVIS® is indicated for the treatment of pain in osteoarthritis (OA) of the knee in patients who have failed to respond adequately to conservative non-pharmacologic therapy or simple analgesics (e.g., acetaminophen). | Hymovis® High Molecular Weight Viscoelastic Hyaluronan, 24mg/3ml syringe | FIDIA FARMACEUTICI SPA |
| 12 | M71389122496630A16 | 89122-4966-30 | 89122-4966-30 | HYMOVIS® is based on an ultra-pure hyaluronan engineered using a proprietary pro HYMOVIS® is based on an ultra-pure hyaluronan engineered using a proprietary process to increase viscosity, elasticity and residence time without chemical crosslinking.The hyaluronan in HYMOVIS® is derived from bacterial fermentation. HYMOVIS® is indicated for the treatment of pain in osteoarthritis (OA) of the knee in patients who have failed to respond adequately to conservative non-pharmacologic therapy or simple analgesics (e.g., acetaminophen). | Hymovis® High Molecular Weight Viscoelastic Hyaluronan, 24mg/3ml syringe | FIDIA FARMACEUTICI SPA |
| 13 | M71389122087901SAM1 | M71389122087901SAM1A | FID10000317 | TriLURON (sodium hyaluronate) 1 prefilled syringe - 2 mL, 20mg per 2 mL - Profes TriLURON (sodium hyaluronate) 1 prefilled syringe - 2 mL, 20mg per 2 mL - Professional Sample - Not for Sale | TriLURON | FIDIA FARMACEUTICI SPA |
| 14 | M71389122087901A1 | M71389122087901A13 | 89122-0879-01 | TriLURON (sodium hyaluronate) 1 prefilled syringe - 2 mL, 20mg per 2 mL | TriLURON | FIDIA FARMACEUTICI SPA |
| 15 | M71389122072420A1 | 89122-0724-20 | 89122-0724-20 | Hyalgan® Sodium Hylauronate (20mg/2mL) in the 2mL syringe is indicated for the t Hyalgan® Sodium Hylauronate (20mg/2mL) in the 2mL syringe is indicated for the treatment of pain in osteoarthritis (OA) of the knee in patients who have failed to respond adequately to conservative nonpharmacologic therapy and to simple analgesics, e.g., acetaminophen. It is a viscous solution of purified natural Sodium Hylauronate (Hyalectin®) in buffered physiological sodium chloride. The sodium hylauronate is extracted from rooster combs. It is given by intra-articular injection in a treatment cycle consisting of five injections given at weekly intervals. Some patients may experience benefit with three injections given at weekly cycles. This has been noted in studies reported in the literature in which patients treated with three injections were followed for 60 days. | Hyalgan® Sodium Hylauronate Pre-filled Syringe - 2mL | FIDIA FARMACEUTICI SPA |
| 16 | M71389122072412A1 | 89122-0724-12 | 89122-0724-12 | Hyalgan® Sodium Hylauronate (20mg/2mL) in the 2mL vial is indicated for the trea Hyalgan® Sodium Hylauronate (20mg/2mL) in the 2mL vial is indicated for the treatment of pain in osteoarthritis (OA) of the knee in patients who have failed to respond adequately to conservative nonpharmacologic therapy and to simple analgesics, e.g., acetaminophen. It is a viscous solution of purified natural Sodium Hylauronate (Hyalectin®) in buffered physiological sodium chloride. The sodium hylauronate is extracted from rooster combs. It is given by intra-articular injection in a treatment cycle consisting of five injections given at weekly intervals. Some patients may experience benefit with three injections given at weekly cycles. This has been noted in studies reported in the literature in which patients treated with three injections were followed for 60 days. | Hyalgan® Sodium Hyaluronate 2mL Vial | FIDIA FARMACEUTICI SPA |
| 17 | M71389122049663SAM1 | FID185704 | FID185704 | HYMOVIS® is based on an ultra-pure hyaluronan engineered using a proprietary pro HYMOVIS® is based on an ultra-pure hyaluronan engineered using a proprietary process to increase viscosity, elasticity and residence time without chemical crosslinking.The hyaluronan in HYMOVIS® is derived from bacterial fermentation. HYMOVIS® is indicated for the treatment of pain in osteoarthritis (OA) of the knee in patients who have failed to respond adequately to conservative non-pharmacologic therapy or simple analgesics (e.g., acetaminophen). It is given by intra-articular injection in two injections given at weekly intervals. | Hymovis® High Molecular Weight Viscoelastic Hyaluronan, 24mg/3ml syringe | FIDIA FARMACEUTICI SPA |
| 18 | M71389122049663A16 | 89122-0496-63 | 89122-0496-63 | HYMOVIS® is based on an ultra-pure hyaluronan engineered using a proprietary pro HYMOVIS® is based on an ultra-pure hyaluronan engineered using a proprietary process to increase viscosity, elasticity and residence time without chemical crosslinking.The hyaluronan in HYMOVIS® is derived from bacterial fermentation. HYMOVIS® is indicated for the treatment of pain in osteoarthritis (OA) of the knee in patients who have failed to respond adequately to conservative non-pharmacologic therapy or simple analgesics (e.g., acetaminophen). It is given by intra-articular injection in two injections given at weekly intervals. | Hymovis® High Molecular Weight Viscoelastic Hyaluronan, 24mg/3ml syringe | FIDIA FARMACEUTICI SPA |
| 19 | M713891220496010 | 89122-0496-01 | 89122-0496-01 | HYMOVIS® is based on an ultra-pure hyaluronan engineered using a proprietary pro HYMOVIS® is based on an ultra-pure hyaluronan engineered using a proprietary process to increase viscosity, elasticity and residence time without chemical crosslinking. The hyaluronan in HYMOVIS® is derived from bacterial fermentation. HYMOVIS® is indicated for the treatment of pain in osteoarthritis (OA) of the knee in patients who have failed to respond adequately to conservative non-pharmacologic therapy or simple analgesics (e.g., acetaminophen). It is given by intra-articular injection in two injections given at weekly intervals. The product is packaged in a one syringe pack. | Hymovis® High Molecular Weight Viscoelastic Hyaluronan, 24mg/3ml syringe, 1 pack | FIDIA FARMACEUTICI SPA |
| 20 | 10886705025183 | 690-016 | 4 mL, 22 mg/mL High Molecular Weight Hyaluronan | Monovisc | ANIKA THERAPEUTICS, INC. | |
| 21 | 10886705023110 | 630-254 | 2 mL, 15 mg/mL High Molecular weight Hyaluronan | Orthovisc | ANIKA THERAPEUTICS, INC. | |
| 22 | 08033638951057 | GS3111 | INTRA-ARTICULAR HYALURONIC ACID. 1 PRE-FILLED SYRINGE CONTAINING 16.8 mg / 2 mL INTRA-ARTICULAR HYALURONIC ACID. 1 PRE-FILLED SYRINGE CONTAINING 16.8 mg / 2 mL HYALURONIC ACID SODIUM SALT | GELSYN-3 | IBSA FARMACEUTICI ITALIA SRL | |
| 23 | 07640128544210 | 4100 | 1% sodium hyaluronate | Euflexxa | FERRING PHARMACEUTICALS INC. | |
| 24 | 05060604130065 | N/A | Monovisc | ACRE PHARMA LIMITED | ||
| 25 | 05060604130041 | N/A | Synvisc | ACRE PHARMA LIMITED | ||
| 26 | 05060604130034 | NA | Inject into the knee to relieve the pain from osteoarthritis. | Synvisc One | ACRE PHARMA LIMITED | |
| 27 | 05060604130027 | NA | Injected into the knee to relieve the pain from osteoarthritis. | Supartz | ACRE PHARMA LIMITED | |
| 28 | 05060604130010 | NA | Inject into the knee to relieve the pain caused by osteoarthritis. | Orthovisc | ACRE PHARMA LIMITED | |
| 29 | 05060604130003 | NA | Injected into the knee to relieve the pain from osteoarthritis. | Euflexxa | ACRE PHARMA LIMITED | |
| 30 | 05060548950071 | N/A | Durolane | PAVAN TRADING LTD | ||
| 31 | 05060548950064 | None | Euflexxa is injected into the knee to relieve the pain of osteoarthritis. | Euflexxa | PAVAN TRADING LTD | |
| 32 | 05060548950057 | None | Supartz is injected into the knee to relieve the pain of osteoarthritis. | Supartz | PAVAN TRADING LTD | |
| 33 | 05060548950033 | None | Monovisc is injected into the knee to relieve the pain of osteoarthritis. | Monovisc | PAVAN TRADING LTD | |
| 34 | 05060548950026 | None | Orthovisc is injected into the knee joint to cushion and lubricate. | Orthovisc | PAVAN TRADING LTD | |
| 35 | 05060548950019 | None | Synvisc is injected into the knee to alleviate the pain of osteoarthritis. | Synvisc One (Synvisc Three) | PAVAN TRADING LTD | |
| 36 | 05060519180056 | NA | Euflexxa | PROPHARMA-UK LTD | ||
| 37 | 05060519180032 | NA | Synvisc One | PROPHARMA-UK LTD | ||
| 38 | 05060519180025 | NA | Supartz | PROPHARMA-UK LTD | ||
| 39 | 05060519180018 | NA | Orthovisc | PROPHARMA-UK LTD | ||
| 40 | 05060519180001 | NA | Hyalgan | PROPHARMA-UK LTD | ||
| 41 | 05060497630048 | 5 Count | Synvisc | PHARMACEUTICAL HEALTH LIMITED | ||
| 42 | 05060497630031 | NA | Supartz | PHARMACEUTICAL HEALTH LIMITED | ||
| 43 | 05060497630024 | NA | Orthovisc | PHARMACEUTICAL HEALTH LIMITED | ||
| 44 | 05060497630017 | NA | Euflexxa | PHARMACEUTICAL HEALTH LIMITED | ||
| 45 | 05060497630000 | NA | Synvisc | PHARMACEUTICAL HEALTH LIMITED | ||
| 46 | 05060459970120 | NA | Supartz | ALLY MEDICAL SUPPLIES LTD | ||
| 47 | 05060459970090 | None | Monovisc | ALLY MEDICAL SUPPLIES LTD | ||
| 48 | 05060459970052 | None | Hyalgan | ALLY MEDICAL SUPPLIES LTD | ||
| 49 | 05060459970045 | None | Euflexxa | ALLY MEDICAL SUPPLIES LTD | ||
| 50 | 05060459970038 | None | Orthovisc | ALLY MEDICAL SUPPLIES LTD |